Clinical Trials Browser

Esophageal Neoplasms

NCT03614949 2026-04-01

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Active not recruiting

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03387553 2026-03-27

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

31 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT05063565 2026-03-27

ROWAN

Phase 2 Active not recruiting

100 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT03384914 2026-03-06

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

119 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT03705806 2026-03-04

Palliative Thoracic ImmunoRT

Active not recruiting

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05863052 2026-02-10

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Active not recruiting

72 enrolled

DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis

Clinical Trials

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

ROWAN

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Palliative Thoracic ImmunoRT

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population